Attention Deficit

Who ya’ going to call? When so much negative publicity surrounds stimulant medication and psychotropic drugs, who can you believe? Well, according to their press release, trust the Journal of Child and Adolescent Psychopharmacology because it "Is The Expert Source on ADHD and the Use of Ritalin in Children."

Journals do provide scientific evidence and controlled studies. However, by their very nature journals are like the old stack of National Geographics found in your grandmother’s basement; typically old, musty, and out of date because of the lag in publication time. So, while they do have their place, it’s important to use the Internet as a place to get the latest data and research as well as warnings – including those posted by the FDA about stimulant medications.

Their press release:

Journal of Child and Adolescent Psychopharmacology Is The Expert Source on ADHD and the Use of Ritalin in Children

Recent and ongoing controversy in the media about the safety and efficacy of psychotropic drugs, especially Ritalin, highlights the need for credible scientific research. Journal of Child and Adolescent Psychopharmacology has been the peer-reviewed journal of record in the field of psychopharmacology since 1991. Noted child psychiatrist Harold S. Koplewicz, M.D., Director, Child Study Center, New York University School of Medicine, Editor-in-Chief of the Journal, contends that the best science in the field does not support the claim that Ritalin may do more harm than good.

The Journal is published by Mary Ann Liebert, Inc., publishers, and selected papers on the treatment of ADHD are available free online through the end of July at www.liebertpub.com/cap.

Journal of Child and Adolescent Psychopharmacology is a peer-reviewed journal published bimonthly in print and online. The Journal is dedicated to child and adolescent psychiatry and behavioral pediatrics, covering clinical and biological aspects of child and adolescent psychopharmacology and developmental neurobiology. A complete table of contents and free sample issue may be viewed online at www.liebertpub.com/cap.

Mary Ann Liebert, Inc., is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including CyberPsychology & Behavior. Its biotechnology trade magazine, Genetic Engineering News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 60 journals, books, and newsletters is available at www.liebertpub.com.